Literature DB >> 1380416

Shigella lipopolysaccharide: structure, genetics, and vaccine development.

H N Brahmbhatt1, A A Lindberg, K N Timmis.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 1380416     DOI： 10.1007/978-3-642-77238-2_3

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  5 in total

Review 1.  Genetics of lipopolysaccharide biosynthesis in enteric bacteria.

Authors:  C A Schnaitman; J D Klena
Journal:  Microbiol Rev       Date:  1993-09

2.  Highly homogenous tri-acylated S-LPS acts as a novel clinically applicable vaccine against Shigella flexneri 2a infection.

Authors:  Vladimir A Ledov; Marina E Golovina; Anna A Markina; Yuriy A Knirel; Vyacheslav L L'vov; Alexander L Kovalchuk; Petr G Aparin
Journal:  Vaccine       Date:  2019-01-19       Impact factor: 3.641

3.  Mutagenesis of the Shigella flexneri autotransporter IcsA reveals novel functional regions involved in IcsA biogenesis and recruitment of host neural Wiscott-Aldrich syndrome protein.

Authors:  Kerrie L May; Renato Morona
Journal:  J Bacteriol       Date:  2008-05-02       Impact factor: 3.490

4.  Development of Shigella sonnei live oral vaccines based on defined rfbInaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide.

Authors:  D Favre; S J Cryz; J F Viret
Journal:  Infect Immun       Date:  1996-02       Impact factor: 3.441

5.  The chemical composition of endotoxin isolated from intestinal strain of Desulfovibrio desulfuricans.

Authors:  Jolanta Lodowska; Daniel Wolny; Marzena Jaworska-Kik; Sławomir Kurkiewicz; Zofia Dzierżewicz; Ludmiła Węglarz
Journal:  ScientificWorldJournal       Date:  2012-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.